Bogle Investment Management’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-83,733
Closed -$3.18M 379
2018
Q4
$3.18M Buy
83,733
+16,010
+24% +$565K 0.25% 121
2018
Q3
$2.9M Buy
+67,723
New +$2.37M 0.21% 130
2017
Q1
Sell
-2,763
Closed -$59K 378
2016
Q4
$59K Sell
2,763
-8,933
-76% -$344K ﹤0.01% 322
2016
Q3
$895K Sell
11,696
-585
-5% -$42.7K 0.06% 263
2016
Q2
$925K Buy
+12,281
New +$989K 0.06% 289

Other funds holding TNDM

Bogle Investment Management's TNDM Position: Q1 2019 in Review

Bogle Investment Management sold out of Tandem Diabetes Care (TNDM) in Q1 2019, closing a stake of 83,733 shares — an estimated $3.18M sold.

Bogle Investment Management first reported a position in TNDM in Q2 2016 and held it in 5 quarters. The position peaked at $3.18M in Q4 2018. 265 funds tracked by Wall St. Rank hold TNDM as of Q1 2019.

  • Bogle Investment Management reported no remaining Tandem Diabetes Care position as of Q1 2019 after selling out during the quarter.
  • Bogle Investment Management sold 83,733 Tandem Diabetes Care shares in Q1 2019, an estimated $3.18M.
  • Bogle Investment Management first reported a position in Tandem Diabetes Care in Q2 2016 and held it in 5 quarters.
  • Bogle Investment Management's Tandem Diabetes Care position peaked at $3.18M in Q4 2018.
  • 265 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2019.

Based on Bogle Investment Management's 13F filing for Q1 2019, filed 13 May 2019.